# Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects

> **NCT01074593** · PHASE1 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Interferon beta-1a
- **BIOLOGICAL:** Interferon beta-1a

## Key facts

- **NCT ID:** NCT01074593
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-03
- **Final completion:** 2011-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01074593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01074593, "Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01074593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*